Holen Sie sich die Stockscreener-App
1.15
7.26%
-0.09
Handel nachbörslich:
1.19
0.04
+3.48%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.25
24-Stunden-Volumen:
92,999
Relative Volume:
0.46
Marktkapitalisierung:
$51.91M
Einnahmen:
$80.28M
Nettoeinkommen (Verlust:
$-38.83M
KGV:
-1.3825
EPS:
-0.8318
Netto-Cashflow:
$-28.67M
1W Leistung:
-11.54%
1M Leistung:
+55.83%
6M Leistung:
+85.48%
1J Leistung:
-22.82%
1-Tages-Spanne:
$1.15
$1.25
1-Wochen-Bereich:
$1.15
$1.37
52-Wochen-Spanne:
$0.5011
$1.60
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.15 | 56.88M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Price Target Announced at $2.00/Share by Craig-Hallum - Moomoo
TELA Bio Initiates Coverage On Craig-Hallum -- Rating Set to Buy - GuruFocus
TELA Looks 9.3% Undervalued on GF Value™ Amid Leadership Changes and Growth Hopes - GuruFocus
TELA Bio Faces Nasdaq Delisting Over Sub-$1 Share Price - Minichart
TELA Bio Faces Nasdaq Delisting, Plans Reverse Split - TipRanks
TELA Bio (TELA) director buys shares outside trading plan - Stock Titan
TELA Bio Received Notice of Delisting - TradingView
TELA Bio Insider Joseph H. Capper Acquires 75,000 Shares at $1.02-$1.06 Between Sept 14-15, 2026 - Kalkine Media
Tela Bio director Capper acquires $78,442 in company stock By Investing.com - Investing.com Australia
TELA Bio (TELA) Director Joseph Capper Buys 75,000 Shares in Ope - GuruFocus
Tela Bio director Capper acquires $78,442 in company stock - Investing.com
TELA Bio (TELA) director adds to stake in open-market buys - stocktitan.net
Reverse split of up to 1-for-15 heads to a vote at TELA Bio (NASDAQ: TELA) after Nasdaq bid-price warning - Stock Titan
Tela Bio Inc (TELA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
TELA Bio Inc. (TELA) Edges Higher on Renewed Buying Interest Near Key Support ZoneMoving Average Crossovers - dars.gov.et
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com South Africa
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position - MyChesCo
Malvern's TELA Bio Cuts Costs 18% and Parts Ways With Longtime COO/CFO Roberto Cuca - BioBuzz
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs - citybiz
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com India
TELA Looks 52.3% Undervalued on GF Value™ Despite Operational Ch - GuruFocus
TELA Bio Implements Workforce Cuts and Leadership Changes - TipRanks
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative - GlobeNewswire
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stak - GuruFocus
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens - MyChesCo
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
TELA Bio (TELA) Drops 5.86% to $0.68 as Micro-Cap Med-Tech Stock Approaches Critical SupportOvernight Profile - vinanet.vn
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – NASDAQ:TELA - TradingView
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
TELA Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 12.4%Analyst Earnings Estimate - dars.gov.et
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tela Bio Inc-Aktie (TELA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Capper Joseph H | Director |
Sep 17 '26 |
Buy |
1.22 |
25,000 |
30,530 |
179,827 |
| Capper Joseph H | Director |
Sep 15 '26 |
Buy |
1.06 |
50,000 |
52,940 |
104,827 |
| Capper Joseph H | Director |
Sep 14 '26 |
Buy |
1.02 |
25,000 |
25,502 |
54,827 |
| Getz Heather C | Chief Executive Officer |
Aug 17 '26 |
Buy |
0.66 |
12,500 |
8,311 |
532,500 |
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):